National Strategic Action Plan for Lung Conditions

Lung disease affects one in four Australians1 and is the second leading cause of death2, yet it struggles to receive the publicity, funding and support required to reduce its impact.

Lung Foundation Australia, together with the support of the Australian Government Department of Health, is working to change the future of lung conditions in Australia by developing the first National Strategic Action Plan for Lung Conditions.

This national plan will define the priorities and actions required to improve lung health and reduce the impact of lung conditions on individuals, the community and the economy.

About the Action Plan

This will be the first National Strategic Action Plan that has been developed to tackle the issue of lung conditions in Australia through a holistic and coordinated approach that is supported by the Australian Government.

The development of a National Strategic Action Plan for Lung Conditions will define the steps required to improve awareness, education, diagnosis, management and research for lung conditions. It will combine the efforts of patients, health professionals, researchers and politicians to acknowledge lung disease as a substantial health burden in Australia, and establish a platform to reduce the impact of lung conditions and improve the outcomes for those affected.

Consultation: Influence the future

We are inviting a wide range of individuals and organisations to be involved in the consultation process, including people with a lung condition or caring for someone with a lung condition, health professionals, research institutions, peak bodies, government and other relevant stakeholders and organisations.

A summary of the results of our recent survey will be published on our website soon.

This summary, combined with reports on the current state of lung health in Australia, will guide our Advisory Group in the development of a draft framework for the plan. This framework will be released for public comment, and the feedback incorporated, before a final draft is submitted to the Federal Government.

Advisory Group

An Advisory Group has been established to oversee the consultation process and development of the action plan. The group members are:

  • Christine Jenkins, Respiratory Physician and Clinical Professor of Medicine, Concord Hospital and UNSW, NSW
  • Kerry Hancock, General Practitioner, Chandlers Hill Surgery, SA
  • Anne Holland, Physiotherapist and Professor, Alfred Health Clinical School, LaTrobe University, Vic.
  • Guy Marks, Professor of Respiratory Medicine, South Western Sydney Clinical School, UNSW, NSW
  • Deb Kay, Chairperson, Health Consumers Alliance of SA
  • Sara McLaughlin Barrett, Thoracic Liaison Nurse Consultant, Monash Medical Centre, Vic.
  • Adam Jaffe, Respiratory Physician and Professor of childhood respiratory conditions, Gosford Hospital and UNSW, NSW
  • Sarath Ranganathan, Respiratory Physician and Professor, The Royal Children’s Hospital Melbourne and Murdoch Children’s Research Institute, Vic.
  • Tanya Buchanan, Chief Executive Officer, Thoracic Society of Australia and New Zealand, NSW
  • Graeme Maguire, Specialist Physician and Professor, Baker IDI Central Australia and Monash University, Vic.
  • Louise Papps, Respiratory Nurse Consultant, Black Swan Health, WA
  • Kerry Hall, Research Fellow, Menzies Health Institute, Qld
  • Judy Powell, Partnerships Manager, Lung Foundation Australia, Qld

For more information, please contact judy@lungfoundation.com.au

1 AIHW, 2016, https://www.aihw.gov.au/reports/australias-health/australiashealth-2016/contents/chapter-3-leading-causes-of-ill-health
2 Lung Disease in Australia, 2014, Woolcock Institute of Medical Research

-->